Evidence map›Paper›PMID 39911669›Full record

ArticleFrontiers in medicine2024

Diverse clinical manifestations and prognosis in a couple's mercury poisoning caused by skin-lightening creams: two case reports and literature review.

Huixia Ji, Ye Chen, Dandan Liu, Tongzhou Zhou, Yuhua Tang

Abstract readCase Reports
In one paragraph

Article in Frontiers in medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Huixia JiDepartment of Occupational Disease, Nanjing Prevention and Treatment Center for Occupational Diseases, Nanjing, China.
Ye ChenDepartment of Occupational Disease, Nanjing Prevention and Treatment Center for Occupational Diseases, Nanjing, China.
Dandan LiuDepartment of Occupational Disease, Nanjing Prevention and Treatment Center for Occupational Diseases, Nanjing, China.
Tongzhou ZhouDepartment of Clinical Laboratory, Nanjing Prevention and Treatment Center for Occupational Diseases, Nanjing, China.
Yuhua TangDepartment of Occupational Disease, Nanjing Prevention and Treatment Center for Occupational Diseases, Nanjing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Skin exposure to mercury-containing creams occurs most commonly in young and middle-aged women and, in a few cases, in men. This article presents the symptoms and prognosis of a couple who developed mercury poisoning after cosmetic use of similar duration and dosage. Case 1 is a 33-year-old man who developed nephrotic syndrome after using skin-lightening creams containing mercury over 9 months. Renal puncture pathology indicated membranous nephropathy. During the course of the illness, the patient intermittently took Chinese medicine. Approximately 4 months later, the patient developed pulmonary thrombosis and lower extremity venous thrombosis as a result of fatigue driving and had to undergo thrombolysis and filter implantation. A urine mercury level of 65.4 μg/g·creatinine was detected in the patient. The urine protein level remained positive 8 months after mercury removal. Case 2 is a 30-year-old woman, the wife of case 1, who used the same creams for 9 months with her husband and had a urine mercury level of 80 μg/g·creatinine. The patient experienced sleep disturbances, fatigue, and irritability. In Case 2, neurasthenia symptoms were relieved following mercury removal, and no other complications were observed. There have been very few reports regarding male patients developing nephrotic syndrome as a consequence of using cosmetics that contain mercury. However, clinicians should not neglect this cause when dealing with newly diagnosed male patients with nephrotic syndrome. The treatment and prognosis of male patients are less well established, and changes in their condition must be closely monitored.

Indexed as

case reportmercury poisoningmercury removal therapynephrotic syndromeprognosis

Identifiers

PMID39911669
PMCPMC11794203

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.